Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use?
Rottier
Bart L
BL
de Boer
Anne H
AH
Duiverman
Eric J
EJ
D000280:Administration, Inhalation; D000336:Aerosols / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D015195:Drug Design; D006801:Humans; D010316:Particle Size; D052638:Particulate Matter / Q000008:administration & dosage*
D000336:Aerosols; D000900:Anti-Bacterial Agents; D052638:Particulate Matter